RecruitingNot ApplicableNCT05019495

Optimizing Tobacco Treatment Delivery for People Living With HIV

Sponsor

Medical University of South Carolina

Enrollment

231 participants

Start Date

Dec 1, 2021

Study Type

INTERVENTIONAL

Conditions

Smoking, Cigarette HIV

Summary

The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate implementation outcomes to identify barriers and facilitators towards future implementation. Investigators hope to define best practices and optimize the delivery of smoking cessation interventions for people living with HIV.

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study tests different ways of helping people living with HIV who smoke to quit tobacco. It compares approaches to see which methods are most effective at delivering tobacco cessation support for this population. **You may be eligible if...** - You are 21 years or older - You have a current diagnosis of HIV - You are currently smoking - You are willing to be randomly assigned to different treatment approaches - You speak English **You may NOT be eligible if...** - You are under 21 years old - You are not currently smoking - You do not speak English - You are unwilling to be randomized Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPrOMOTE

This is an opt-out, proactive approach to tobacco treatment by a clinical pharmacy specialist. The pharmacist will call patients and offer an individualized pharmacotherapy prescription. The patient must opt-out for it not to be sent to their pharmacy. The patient will also receive brief motivational interviewing and behavioral counseling from the pharmacist.

Locations(1)

Medical University of South Carolina

Charleston, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05019495

Related Trials

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

NCT0739095512 locations

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

NCT064443602 locations

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

NCT000065181 location

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

NCT000294451 location

Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV

NCT000012812 locations